These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 31802872)

  • 1. A Nanodrug Consisting Of Doxorubicin And Exosome Derived From Mesenchymal Stem Cells For Osteosarcoma Treatment In Vitro.
    Wei H; Chen J; Wang S; Fu F; Zhu X; Wu C; Liu Z; Zhong G; Lin J
    Int J Nanomedicine; 2019; 14():8603-8610. PubMed ID: 31802872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenchymal Stem Cell Derived Exosomes as Nanodrug Carrier of Doxorubicin for Targeted Osteosarcoma Therapy via SDF1-CXCR4 Axis.
    Wei H; Chen F; Chen J; Lin H; Wang S; Wang Y; Wu C; Lin J; Zhong G
    Int J Nanomedicine; 2022; 17():3483-3495. PubMed ID: 35959282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosome mimetics derived from bone marrow mesenchymal stem cells ablate neuroblastoma tumor in vitro and in vivo.
    Li M; Wang J; Guo P; Jin L; Tan X; Zhang Z; Zhanghuang C; Mi T; Liu J; Wang Z; Wu X; Wei G; He D
    Biomater Adv; 2022 Nov; 142():213161. PubMed ID: 36308859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doxorubicin Delivered Using Nanoparticles Camouflaged with Mesenchymal Stem Cell Membranes to Treat Colon Cancer.
    Liu Y; Zhao J; Jiang J; Chen F; Fang X
    Int J Nanomedicine; 2020; 15():2873-2884. PubMed ID: 32368059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosome mimetics derived from bone marrow mesenchymal stem cells deliver doxorubicin to osteosarcoma
    Wang J; Li M; Jin L; Guo P; Zhang Z; Zhanghuang C; Tan X; Mi T; Liu J; Wu X; Wei G; He D
    Drug Deliv; 2022 Dec; 29(1):3291-3303. PubMed ID: 36352741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted doxorubicin-loaded mesenchymal stem cells-derived exosomes as a versatile platform for fighting against colorectal cancer.
    Bagheri E; Abnous K; Farzad SA; Taghdisi SM; Ramezani M; Alibolandi M
    Life Sci; 2020 Nov; 261():118369. PubMed ID: 32882265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Glioma Cells' Proliferation by Doxorubicin-Loaded Exosomes via Microfluidics.
    Thakur A; Sidu RK; Zou H; Alam MK; Yang M; Lee Y
    Int J Nanomedicine; 2020; 15():8331-8343. PubMed ID: 33149579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chitooligosaccharides Modified Reduction-Sensitive Liposomes: Enhanced Cytoplasmic Drug Delivery and Osteosarcomas-Tumor Inhibition in Animal Models.
    Yin X; Chi Y; Guo C; Feng S; Liu J; Sun K; Wu Z
    Pharm Res; 2017 Oct; 34(10):2172-2184. PubMed ID: 28726003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of tumor-targeting peptide-decorated polypeptide nanoparticles with doxorubicin to treat osteosarcoma.
    Qiu R; Sun D; Bai Y; Li J; Wang L
    Drug Deliv; 2020 Nov; 27(1):1704-1717. PubMed ID: 33305647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-199a-modified exosomes from adipose tissue-derived mesenchymal stem cells improve hepatocellular carcinoma chemosensitivity through mTOR pathway.
    Lou G; Chen L; Xia C; Wang W; Qi J; Li A; Zhao L; Chen Z; Zheng M; Liu Y
    J Exp Clin Cancer Res; 2020 Jan; 39(1):4. PubMed ID: 31898515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen-functionalized liposomes grafted with glutathione-responsive sheddable chotooligosaccharides for the therapy of osteosarcoma.
    Yin X; Feng S; Chi Y; Liu J; Sun K; Guo C; Wu Z
    Drug Deliv; 2018 Nov; 25(1):900-908. PubMed ID: 29644882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AS1411 aptamer-functionalized exosomes in the targeted delivery of doxorubicin in fighting colorectal cancer.
    Hosseini NF; Amini R; Ramezani M; Saidijam M; Hashemi SM; Najafi R
    Biomed Pharmacother; 2022 Nov; 155():113690. PubMed ID: 36099793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosomal LncRNA-NEAT1 derived from MIF-treated mesenchymal stem cells protected against doxorubicin-induced cardiac senescence through sponging miR-221-3p.
    Zhuang L; Xia W; Chen D; Ye Y; Hu T; Li S; Hou M
    J Nanobiotechnology; 2020 Oct; 18(1):157. PubMed ID: 33129330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoparticles-encapsulated doxorubicin alleviates drug resistance of osteosarcoma via inducing ferroptosis.
    Tian X; Zhang Y; Zhang M; Liu G; Hao Y; Liu W
    Nanotoxicology; 2024 Jun; 18(4):401-409. PubMed ID: 38907601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doxorubicin-loaded amphiphilic polypeptide-based nanoparticles as an efficient drug delivery system for cancer therapy.
    Lv S; Li M; Tang Z; Song W; Sun H; Liu H; Chen X
    Acta Biomater; 2013 Dec; 9(12):9330-42. PubMed ID: 23958784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of Dynamin-Related Protein 1 and Induction of Mitochondrial Apoptosis by Exosome-Rifampicin Nanoparticles Exerts Anti-Osteosarcoma Effect.
    Chen W; Lin W; Yu N; Zhang L; Wu Z; Chen Y; Li Z; Gong F; Li N; Chen X; He X; Wu Y; Zeng X; Yueh Y; Xu R; Ji G
    Int J Nanomedicine; 2022; 17():5431-5446. PubMed ID: 36426375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of platelet exosomes loaded with doxorubicin as a targeted therapy on triple-negative breast cancer cells.
    Uslu D; Abas BI; Demirbolat GM; Cevik O
    Mol Divers; 2024 Apr; 28(2):449-460. PubMed ID: 36576666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-delivery of doxorubicin and paclitaxel by reduction/pH dual responsive nanocarriers for osteosarcoma therapy.
    Li Y; Hou H; Zhang P; Zhang Z
    Drug Deliv; 2020 Dec; 27(1):1044-1053. PubMed ID: 32633576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanosomes carrying doxorubicin exhibit potent anticancer activity against human lung cancer cells.
    Srivastava A; Amreddy N; Babu A; Panneerselvam J; Mehta M; Muralidharan R; Chen A; Zhao YD; Razaq M; Riedinger N; Kim H; Liu S; Wu S; Abdel-Mageed AB; Munshi A; Ramesh R
    Sci Rep; 2016 Dec; 6():38541. PubMed ID: 27941871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exosomes Derived from Human Bone Marrow Mesenchymal Stem Cells Promote Tumor Growth Through Hedgehog Signaling Pathway.
    Qi J; Zhou Y; Jiao Z; Wang X; Zhao Y; Li Y; Chen H; Yang L; Zhu H; Li Y
    Cell Physiol Biochem; 2017; 42(6):2242-2254. PubMed ID: 28817816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.